1-2 of 2
Douglas V. Faller
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Targeted therapy with nanatinostat and valganciclovir in recurrent EBV-positive lymphoid malignancies: a phase 1b/2 study

Clinical Trials & Observations
Bradley Haverkos, Onder Alpdogan, Robert Baiocchi, Jonathan E. Brammer, Tatyana A. Feldman, Marcelo Capra, Elizabeth A. Brem, Santosh Nair, Phillip Scheinberg, Juliana Pereira, Leyla Shune, Erel Joffe, Patricia Young, Susan Spruill, Afton Katkov, Robert McRae, Ivor Royston, Douglas V. Faller, Lisa Rojkjaer, Pierluigi Porcu
Journal: Blood Advances
Blood Adv (2023) 7 (20): 6339–6350.
https://doi.org/10.1182/bloodadvances.2023010330
Published: 2023
Includes: Supplemental data
Journal Articles

Pevonedistat plus azacitidine vs azacitidine alone in higher-risk MDS/chronic myelomonocytic leukemia or low-blast-percentage AML

Clinical Trials & Observations
Lionel Adès, Larisa Girshova, Vadim A. Doronin, María Díez-Campelo, David Valcárcel, Suman Kambhampati, Nora-Athina Viniou, Dariusz Woszczyk, Raquel De Paz Arias, Argiris Symeonidis, Achilles Anagnostopoulos, Eduardo Ciliao Munhoz, Uwe Platzbecker, Valeria Santini, Robert J. Fram, Ying Yuan, Sharon Friedlander, Douglas V. Faller, Mikkael A. Sekeres
Journal: Blood Advances
Blood Adv (2022) 6 (17): 5132–5145.
https://doi.org/10.1182/bloodadvances.2022007334
Published: 2022
Includes: Supplemental data